Personalis Stock (NASDAQ: PSNL) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 6.000 / 347.177K |
Day Range | - - - |
52 Wk Range | 0.891 - 2.600 |
Market Cap | $67.085M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 45 |
Short Interest | 4.04% |
Days to Cover | 3.68 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Personalis (NASDAQ: PSNL) through any online brokerage.
Other companies in Personalis’s space includes: Harvard Bioscience (NASDAQ:HBIO), Codexis (NASDAQ:CDXS), Quantum-Si (NASDAQ:QSI), Applied DNA Sciences (NASDAQ:APDN) and Inotiv (NASDAQ:NOTV).
The latest price target for Personalis (NASDAQ: PSNL) was reported by Needham on Thursday, April 11, 2024. The analyst firm set a price target for 3.50 expecting PSNL to rise to within 12 months (a possible 167.18% upside). 8 analyst firms have reported ratings in the last year.
The stock price for Personalis (NASDAQ: PSNL) is $1.31 last updated April 22, 2024 at 9:30 AM EDT.
There are no upcoming dividends for Personalis.
Personalis’s Q1 earnings are confirmed for Monday, May 6, 2024.
There is no upcoming split for Personalis.
Personalis is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the NASDAQ.